However, the recent identification of new HA-degrading enzymes, KIAA1199 [14] and transmembrane 2 (TMEM2) [17], has prompted us and others to determine the mechanism of HA degradation in OA or RA patients. This evidence concerns the gene CEMIP2 and rheumatoid arthritis.